146 related articles for article (PubMed ID: 27020111)
21. Impact of intensity-modulated radiotherapy on health-related quality of life for head and neck cancer patients: matched-pair comparison with conventional radiotherapy.
Graff P; Lapeyre M; Desandes E; Ortholan C; Bensadoun RJ; Alfonsi M; Maingon P; Giraud P; Bourhis J; Marchesi V; Mège A; Peiffert D
Int J Radiat Oncol Biol Phys; 2007 Apr; 67(5):1309-17. PubMed ID: 17289292
[TBL] [Abstract][Full Text] [Related]
22. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
[TBL] [Abstract][Full Text] [Related]
23. Phase 2 trial of concurrent 5-fluorouracil, hydroxyurea, cetuximab, and hyperfractionated intensity-modulated radiation therapy for locally advanced head and neck cancer.
Kao J; Genden EM; Gupta V; Policarpio EL; Burri RJ; Rivera M; Gurudutt V; Som PM; Teng M; Packer SH
Cancer; 2011 Jan; 117(2):318-26. PubMed ID: 20830768
[TBL] [Abstract][Full Text] [Related]
24. 0-7-21 hypofractionated palliative radiotherapy: an effective treatment for advanced head and neck cancers.
Nguyen NT; Doerwald-Munoz L; Zhang H; Kim DH; Sagar S; Wright JR; Hodson DI
Br J Radiol; 2015 May; 88(1049):20140646. PubMed ID: 25694259
[TBL] [Abstract][Full Text] [Related]
25. Phase II study of weekly docetaxel and cisplatin in patients with advanced recurrent and metastatic head and neck cancer.
Guntinas-Lichius O; Appenrodt S; Veelken F; Krug B
Laryngoscope; 2006 Apr; 116(4):613-8. PubMed ID: 16585868
[TBL] [Abstract][Full Text] [Related]
26. Changing quality of life in patients with advanced head and neck cancer after primary radiotherapy or chemoradiation.
Fang FM; Tsai WL; Chien CY; Chiu HC; Wang CJ; Chen HC; Hsiung CY
Oncology; 2005; 68(4-6):405-13. PubMed ID: 16020970
[TBL] [Abstract][Full Text] [Related]
27. What Did the Pandemic Teach Us About Palliative Radiation in Head and Neck Cancer?
Ghoshal S; Singla AK; Ballari N; Gupta A
J Palliat Care; 2022 Jul; 37(3):317-322. PubMed ID: 34866493
[No Abstract] [Full Text] [Related]
28. Clinical investigation: Reliability and validity of the Japanese version of quality of life radiation therapy instrument (QOL-RTI) for Japanese patients with head and neck malignancies.
Karasawa K; Sasaki T; Okawa T; Takahashi T; Hayakawa K; Ohizumi Y; Tamaki Y; Makino M; Kobyashi M; Shibayama C; Saitou T; Johnson DJ
J Oncol Manag; 2003; 12(2):18-24. PubMed ID: 12699112
[TBL] [Abstract][Full Text] [Related]
29. Quality of life and performance in advanced head and neck cancer patients on concomitant chemoradiotherapy: a prospective examination.
List MA; Siston A; Haraf D; Schumm P; Kies M; Stenson K; Vokes EE
J Clin Oncol; 1999 Mar; 17(3):1020-8. PubMed ID: 10071297
[TBL] [Abstract][Full Text] [Related]
30. Combined intensity-modulated radiotherapy plus raster-scanned carbon ion boost for advanced adenoid cystic carcinoma of the head and neck results in superior locoregional control and overall survival.
Jensen AD; Nikoghosyan AV; Poulakis M; Höss A; Haberer T; Jäkel O; Münter MW; Schulz-Ertner D; Huber PE; Debus J
Cancer; 2015 Sep; 121(17):3001-9. PubMed ID: 26043145
[TBL] [Abstract][Full Text] [Related]
31. Intensity-modulated radiotherapy with concurrent chemotherapy for previously irradiated, recurrent head and neck cancer.
Biagioli MC; Harvey M; Roman E; Raez LE; Wolfson AH; Mutyala S; Han HS; Markoe A
Int J Radiat Oncol Biol Phys; 2007 Nov; 69(4):1067-73. PubMed ID: 17967302
[TBL] [Abstract][Full Text] [Related]
32. Short-course accelerated radiotherapy in palliative treatment of advanced pelvic malignancies: a phase I study.
Caravatta L; Padula GD; Macchia G; Ferrandina G; Bonomo P; Deodato F; Massaccesi M; Mignogna S; Tambaro R; Rossi M; Flocco M; Scapati A; Scambia G; Pacelli F; Valentini V; Cellini N; Morganti AG
Int J Radiat Oncol Biol Phys; 2012 Aug; 83(5):e627-31. PubMed ID: 22580117
[TBL] [Abstract][Full Text] [Related]
33. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
[TBL] [Abstract][Full Text] [Related]
34. Recurrences near base of skull after IMRT for head-and-neck cancer: implications for target delineation in high neck and for parotid gland sparing.
Eisbruch A; Marsh LH; Dawson LA; Bradford CR; Teknos TN; Chepeha DB; Worden FP; Urba S; Lin A; Schipper MJ; Wolf GT
Int J Radiat Oncol Biol Phys; 2004 May; 59(1):28-42. PubMed ID: 15093896
[TBL] [Abstract][Full Text] [Related]
35. Intensity-modulated radiotherapy for head-and-neck cancer in the community setting.
Seung S; Bae J; Solhjem M; Bader S; Gannett D; Hansen EK; Louie J; Underhill K; Cha C
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1075-81. PubMed ID: 18486355
[TBL] [Abstract][Full Text] [Related]
36. Quality of Life Analysis of a Radiation Dose-Escalation Study of Patients With Non-Small-Cell Lung Cancer: A Secondary Analysis of the Radiation Therapy Oncology Group 0617 Randomized Clinical Trial.
Movsas B; Hu C; Sloan J; Bradley J; Komaki R; Masters G; Kavadi V; Narayan S; Michalski J; Johnson DW; Koprowski C; Curran WJ; Garces YI; Gaur R; Wynn RB; Schallenkamp J; Gelblum DY; MacRae RM; Paulus R; Choy H
JAMA Oncol; 2016 Mar; 2(3):359-67. PubMed ID: 26606200
[TBL] [Abstract][Full Text] [Related]
37. Preoperative hyperfractionated accelerated radiotherapy and radical surgery in advanced head and neck cancer: a prospective phase II study.
Lindholm P; Valavaara R; Aitasalo K; Kulmala J; Laine J; Elomaa L; Sillanmäki L; Minn H; Grénman R
Radiother Oncol; 2006 Feb; 78(2):146-51. PubMed ID: 16307813
[TBL] [Abstract][Full Text] [Related]
38. Trismus in head and neck cancer patients treated by telecobalt and effect of early rehabilitation measures.
Nagaraja S; Kadam SA; Selvaraj K; Ahmed I; Javarappa R
J Cancer Res Ther; 2016; 12(2):685-8. PubMed ID: 27461633
[TBL] [Abstract][Full Text] [Related]
39. Intensity-modulated radiation treatment for head-and-neck squamous cell carcinoma--the University of Iowa experience.
Yao M; Dornfeld KJ; Buatti JM; Skwarchuk M; Tan H; Nguyen T; Wacha J; Bayouth JE; Funk GF; Smith RB; Graham SM; Chang K; Hoffman HT
Int J Radiat Oncol Biol Phys; 2005 Oct; 63(2):410-21. PubMed ID: 16168834
[TBL] [Abstract][Full Text] [Related]
40. Concomitant low-dose cisplatin and three-dimensional conformal radiotherapy for locally advanced squamous cell carcinoma of the head and neck: Analysis of survival and toxicity.
Lau H; Brar S; Hao D; MacKinnon J; Yee D; Gluck S
Head Neck; 2006 Mar; 28(3):189-96. PubMed ID: 16265658
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]